BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy

Jonathan Fletcher, Mohammad H Derakhshan, Gareth Jones, Angela A Wirz, Kenneth E L McColl

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

In most patients undergoing endoscopy for upper gastrointestinal (GI) symptoms in the Western world, no macroscopic abnormality or evidence of Helicobacter pylori infection is identified. Following this negative investigation, proton pump inhibitor (PPI) therapy is usually prescribed. The aim of this study was to assess the value of such treatment compared with placebo and to identify predictors of response.
Original languageEnglish
Pages (from-to)442-8
Number of pages7
JournalGut
Volume60
Issue number4
DOIs
Publication statusPublished - 2011

Fingerprint

Dive into the research topics of 'BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopy'. Together they form a unique fingerprint.

Cite this